Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer
CD4+ T helper antigens are essential components of cancer vaccines, but the relevance of the source of these MHC class II-restricted antigens remains underexplored. To compare the effectiveness of tumor-specific versus tumor-unrelated helper antigens, we designed three DNA vaccines for the murine MC...
Saved in:
| Main Authors: | Joanna Fréderique de Graaf, Tamara Pesic, Felicia S. Spitzer, Koen Oosterhuis, Marcel G.M. Camps, Iris Zoutendijk, Bram Teunisse, Wahwah Zhu, Tsolere Arakelian, Gerben C. Zondag, Ramon Arens, Jeroen van Bergen, Ferry Ossendorp |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-09-01
|
| Series: | Molecular Therapy: Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950329924000778 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid and direct discovery of functional tumor specific neoantigens by high resolution mass spectrometry and novel algorithm prediction
by: Huajian Tian, et al.
Published: (2025-06-01) -
Antitumor mRNA vaccines based on neoantigens
by: E. V. Starostina, et al.
Published: (2025-01-01) -
Depletion of regulatory T cells enhances the T cell response induced by the neoantigen vaccine with weak immunogenicity
by: Ruichen Huang, et al.
Published: (2025-01-01) -
Advancements and challenges in personalized neoantigen-based cancer vaccines
by: Parminder Singh, et al.
Published: (2025-03-01) -
Neoantigen prioritization based on antigen processing and presentation
by: Serina Tokita, et al.
Published: (2024-11-01)